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Associations of Blood Pressure in Pregnancy With Offspring Blood
Pressure Trajectories During Childhood and Adolescence: Findings
From a Prospective Study
James R. Staley, MSc; John Bradley, PhD; Richard J. Silverwood, PhD; Laura D. Howe, PhD; Kate Tilling, PhD; Debbie A. Lawlor, PhD;
Corrie Macdonald-Wallis, PhD
Background-—Hypertensive disorders of pregnancy are related to higher offspring blood pressure (BP), but it is not known whether
this association strengthens or weakens as BP changes across childhood. Our aim was to assess the associations of hypertensive
disorders of pregnancy and maternal BP changes during pregnancy with trajectories of offspring BP from age 7 to 18 years.
Methods and Results-—In a large UK cohort of maternal–offspring pairs (N=6619), we used routine antenatal BP measurements to
derive hypertensive disorders of pregnancy and maternal BP trajectories. These were related to offspring BP trajectories, obtained
from research clinic assessments, using linear spline random-effects models. After adjusting for maternal and offspring variables,
including body mass index, offspring of women who had existing hypertension, gestational hypertension, or preeclampsia during
pregnancy had on average higher BP at age 7 years compared to offspring of normotensive pregnancies (mean difference [95%CI]
in systolic BP: 1.67 mm Hg [0.48, 2.86], 1.98 mm Hg [1.32, 2.65], and 1.22 mm Hg [0.52, 2.97], respectively). These
differences were consistent across childhood to age 18 years, as the patterns of BP change did not differ between offspring of
hypertensive pregnancies and normotensive pregnancies. Maternal BP at 8 weeks’ gestation was also positively associated with
offspring BP in childhood and adolescence, but changes in BP across pregnancy were not strongly associated.
Conclusions-—The differences in BP between offspring of hypertensive pregnancies and offspring of normotensive pregnancies
remain consistent across childhood and adolescence. These associations appear to be most contributed to by higher maternal BP
in early pregnancy rather than by pregnancy-related BP changes. ( J Am Heart Assoc.2015;4:e001422 doi: 10.1161/
JAHA.114.001422)
Key Words: ALSPAC • blood pressure • change • childhood • gestational hypertension • preeclampsia • pregnancy
H ypertensive disorders of pregnancy (HDP) includepregnancy-induced hypertension (ie, gestational hyper-
tension and preeclampsia) and also hypertension that exists
prior to pregnancy (referred to as existing hypertension here).
Pregnancy-induced hypertension is deﬁned as newly elevated
blood pressure (BP) after 20 weeks of gestation, with
preeclampsia being distinguished from gestational hyperten-
sion by the presence of proteinuria.1 Preeclampsia is also
characterized by systemic inﬂammation, insulin resistance,
and endothelial dysfunction.2–5
Preeclampsia and gestational hypertension have been
shown to be associated with higher BP in offspring during
childhood and adolescence.6–15 However, it is not clear how
this association compares with the association of existing
hypertension with offspring BP.16 Despite the different forms
of HDP having different clinical manifestations, there is clear
overlap between them, and increasing evidence that they may
not be entirely distinct conditions, with higher BP (even within
the normal range) prior to pregnancy predisposing to the
development of preeclampsia.17 In addition, existing hyper-
tension has recently been shown to be strongly associated
with the risk of a similar range of perinatal factors, including
perinatal mortality, preterm delivery, and low birth weight, to
preeclampsia and gestational hypertension.18,19 Comparing
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BP across offspring of pregnancies affected by existing
hypertension, gestational hypertension, preeclampsia, and
offspring of normotensive pregnancies may provide informa-
tion about the mechanisms inﬂuencing the associations and
whether there are distinct or common pathways involved for
each of the forms of HDP.7
BP increases with age during childhood and adoles-
cence,20–27 with some studies suggesting that BP decreases
in females in late adolescence.23–27 Previous studies that
examined associations of HDP with offspring BP have all
focused on a single measurement occasion, and no studies to
our knowledge have assessed whether HDP is associated with
age-related changes in BP across childhood and adolescence
using repeated measurements of BP. This would provide
information about the development of cardiovascular risk,
and whether the differences seen in BP during childhood
between offspring of normotensive and hypertensive preg-
nancies become smaller as the child ages or strengthen into
adulthood.
An additional way of examining the reported association
between maternal HDP and offspring BP is to assess the
maternal trajectory of BP change during pregnancy. Despite
HDP being deﬁned by thresholds of BP, pregnancy is a period
of considerable BP change, and both the BP level in early
pregnancy and the rate of increase in BP in late pregnancy is
greater in hypertensive pregnancies.28 Hence, identifying
whether the early-pregnancy BP level or the rate of increase in
BP during late pregnancy is more strongly related to changes
in BP in the offspring may suggest whether the associations
between HDP and higher offspring BP are driven by a common
underlying predisposition to high BP between mother and
child or to factors directly related to the pregnancy.
Thus, the aim of this study was to investigate the
associations of HDP (existing hypertension, gestational
hypertension and preeclampsia) and of maternal BP changes




The Avon Longitudinal Study of Parents and Children (ALSPAC)
is a prospective population-based birth cohort study that
recruited 14 541 pregnant women resident in Avon, United
Kingdom with expected dates of delivery April 1, 1991 to
December 31, 1992 and is fully described elsewhere.29,30 The
study website contains details of all the data that are available
through a fully searchable data dictionary (http://www.bris.
ac.uk/alspac/researchers/data-access/data-dictionary). All
children were invited to attend research clinics between the
ages of 7 and 17 years. Ethical approval for the study was
obtained from the ALSPAC Ethics and Law Committee and the
Local Research Ethics Committees. In this study, we considered
the 9014 mother–offspring pairs where there was a singleton
pregnancy resulting in a live birth and where the child had their
BP measured at least once. The small number of mothers with
existing diabetes (N=32) or gestational diabetes (N=45) were
excluded. Mothers who did not have their BP measured during
pregnancy were omitted from all analyses, and mothers who
had fewer than 2 BP measurements after 20 weeks of
pregnancy were omitted from the HDP analysis. After these
exclusions, 8443 and 8617 mother–offspring pairs were
available for the HDP and maternal BP analyses, respectively.
Maternal Pregnancy Data
All maternal systolic blood pressure (SBP), diastolic blood
pressure (DBP), and urine dipstick proteinuria measurements
taken in routine clinical practice were abstracted from
obstetric medical records by 6 trained research midwives.
The median number (lower quartile, upper quartile) of BP and
urine measurements taken during pregnancy were 14 (11,
16) and 11 (10, 14) respectively. Women who reported
having previously been diagnosed with high BP outside of
pregnancy are referred to as having existing hypertension
throughout the remainder of this article. For women without
existing hypertension, HDP was deﬁned according to the
International Society for the Study of Hypertension in
Pregnancy criteria:1 gestational hypertension was deﬁned
as either having SBP≥140 mm Hg or DBP≥90 mm Hg on at
least 2 occasions after 20 weeks of gestation; preeclampsia
was deﬁned using the same criteria with proteinuria of at
least 1+ on dipstick testing occurring at the same time as
the elevated BP. Thus, all the women were categorized into 1
of 4 mutually exclusive categories: no evidence of hyperten-
sion, existing hypertension, gestational hypertension, or
preeclampsia.
Other Maternal or Parental Characteristics
Maternal age, parity, gestational age at delivery, and mode of
delivery were obtained from the obstetric records. At the time
of recruitment, the women were asked to report their
prepregnancy height and weight, which were used to calculate
their prepregnancy body mass index (BMI). Parental occupa-
tion was classiﬁed into social class groups from I (profes-
sional/managerial) to V (unskilled manual workers) using the
1991 British Ofﬁce of Population and Census Statistics
classiﬁcation and the highest of both parents was deﬁned as
the head of household social class. Maternal smoking was
categorized as never smoked, smoked before pregnancy or in
the ﬁrst trimester and then stopped, and smoked throughout
pregnancy. The highest educational qualiﬁcation of the
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mother was also obtained from a questionnaire administered
during pregnancy.
Offspring Characteristics
The birth weight and gender of every child were abstracted
from the obstetric medical records. Current ages of the
children were recorded in months upon their arrival at each of
the 7 follow-up clinics (7-, 9-, 10-, 11-, 13-, 15-, and 17-year).
At all of the clinics, SBP and DBP were measured twice with
the child at rest using the appropriate cuff size for the upper
arm circumference, and the mean of each was recorded.
These SBP and DBP means were used in all the subsequent
analyses. BP was measured using a Dinamap 9301 Vital Signs
Monitor at the 7, 9, 11, 15, and 17-year clinics, an Omron MI-
5 at the 10-year clinic, and a Dinamap 8100 Vital Signs
Monitor at the 13-year clinic. Height and weight measure-
ments of the children were also recorded at each follow-up
clinic, and were used to calculate the child’s BMI at each
clinic.
Statistical Methods
The offspring BP measurements are clustered within the
offspring, and hence multilevel models with 2 levels (follow-up
clinic [level 1] within the offspring [level 2]) were used to
account for the correlation between repeated BP measure-
ments on the same offspring.31 There were few observations
before the age of 7 years and hence this point was used as
the baseline. Linear spline random-effects models with knots
at 12 and 16 years of age were used to describe the
trajectories of SBP and DBP change with age. Fractional
polynomial curves ﬁtted to the repeated BP measurements of
all 9014 offspring with at least 1 BP were used to determine
these approximated knot points. This yielded 4 child-level
random-effects parameters: SBP/DBP at 7 years, SBP/DBP
change from 7 to 12 years, SBP/DBP change from 12 to
16 years, and SBP/DBP change after 16 years.
A ﬁxed effect indicating those offspring BP measurements
made at the 10-year clinic was included as the measurements
made at this clinic were not consistent with those made at the
9-year and 11-year clinics due to the different measuring
device used. In addition, the offspring follow-up clinic level
variance was allowed to be different before and after 10 years
of age as this improved the model ﬁt.
The maternal BP measurements are clustered within
mothers, and thus multilevel models were also used to
account for the correlation between repeated BP measures
during pregnancy on the same mother. Linear splines with
knots at 18, 30, and 36 weeks’ gestation, chosen according
to the best ﬁt to the data, were used for maternal BP
trajectories as in previous analyses,32 and baseline was set at
8 weeks of gestation because there were few observations
before this point.
Associations of Maternal HDP With Offspring BP
Change
To investigate the association of HDP with offspring BP
trajectories, multivariable linear spline models were ﬁtted to
the 6619 individuals with complete data on all covariables.
We initially ﬁtted an unadjusted model, including only HDP
category as the exposure (Model 1). This was included as a
categorical main effect, and as an interaction with each of the
splines, in order to examine its associations with offspring BP
at age 7 years and with the rates of change in BP in each
period of childhood and adolescence. Model 2 adjusts for the
maternal characteristics (prepregnancy BMI, maternal age,
education, parity, and smoking during pregnancy), household
social class, and offspring gender, by including these as main
effects and interactions with each of the splines. Model 3
additionally accounts for offspring BMI and height at ages 7 to
17 from each of the clinics (adjusting for weight at ages 7 to
17 in place of BMI gave equivalent results), by including these
as time-varying confounders. Although offspring height and
BMI occur after the exposure of interest (HDP), we considered
them to be part of the confounding pathway through their
relationship and shared determinants with maternal BMI.
Model 4 also controls for perinatal factors that could be
potential mediators of associations if they were acting via
intrauterine mechanisms (birth weight, gestational age, and
mode of delivery), by including these as main effects and
interactions with each of the splines.
Bivariate Linear Spline Models of Maternal and
Offspring BP Change
To evaluate the associations of maternal BP changes during
pregnancy with offspring BP trajectories, we ﬁtted bivariate
linear spline models to 6619 mother–offspring pairs where
there were complete data on all covariates. Bivariate linear
spline random-effects models were ﬁtted separately including
maternal SBP and offspring SBP as outcomes, and including
maternal DBP and offspring DBP as outcomes. To prevent
mothers with many BP measurements having too much
inﬂuence on the models, we randomly sampled 1 measure-
ment for every 2-week period of gestation. Regression
coefﬁcients of the associations between maternal BP change
and offspring BP change were obtained from the covariance
matrix of random effects from the bivariate models using the
reffadjust command in Stata.33
In this analysis, we assessed 3 models: a minimally
adjusted model (Model 1) where we only adjusted for maternal
BP at baseline (8 weeks’ gestation) and maternal BP changes
in any earlier periods of gestation; a confounder-adjusted
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model (Model 2) where we additionally adjusted for maternal
characteristics, household social class, and offspring gender,
height, and BMI; and a model that controls for potential
intrauterine mediators (Model 3). A detailed description of
covariate adjustment is given in the footnotes of relevant
tables (Tables 5 and 6). As before, all confounders and
mediators were included as main effects and interactions with
each of the splines, except for offspring BMI and height, which
were included as time-varying confounders in the offspring BP
part of the model.
To examine whether any associations found were being
completely driven by women who had HDP, we repeated the
analysis restricting only to mother–offspring pairs where the
mother had a normotensive pregnancy.
Sensitivity Analyses
We completed several sensitivity analyses. In the ﬁrst we
additionally included breastfeeding up to 6 months in medi-
ator-adjusted models to consider this as an additional
potential mediator of the associations of HDP and maternal
BP change with offspring BP. Second, we excluded offspring
and mothers who had few (<3 and <5 BP measurements) and
mothers who had many (>9 and >11 BP measurements) BP
measurements available. Finally, to examine whether the use
of antihypertensive medication affected our ﬁndings, we
excluded the 33 women who had existing hypertension and
reported using medication to treat their hypertension and the
26 women who reported using antihypertensives, b-blockers
or calcium-channel blockers (for any reason) regularly, or at
any time, during their pregnancy.
Statistical analyses were carried out using MLwiN version
2.27 and Stata version 12.1 combined with runmlwin.34
Results
Among the 8443 mother–offspring pairs where the mother
had at least 2 BP measurements after 20 weeks of gestation,
6716 (79.5%) had no HDP, 310 (3.7%) had existing hyperten-
sion, 1256 (14.9%) had gestational hypertension, and 161
(1.9%) had preeclampsia (Table 1). These proportions were
similar in the 6619 mother–offspring pairs with complete data
on all covariables (Table 1). There was strong evidence
(P<0.001) that HDP status was associated with maternal
prepregnancy BMI, parity, and smoking during pregnancy as
well as with gestational age, birth weight, and mode of
delivery (Table 2).
Associations of HDP With Offspring BP Changes
The average SBP and DBP for those offspring whose mothers
had any form of HDP (existing hypertension, gestational
hypertension, or preeclampsia) during pregnancy were mark-
edly higher throughout childhood and adolescence compared
to those offspring whose mothers had normotensive preg-
nancies (Figure). However, the rates of offspring SBP and DBP
change in each of the age intervals were similar across
hypertensive and normotensive pregnancies, with offspring
SBP and DBP on average increasing through late childhood (7
to 12 years) and more rapidly through early adolescence (12
to 16 years), and then decreasing through the latter part of
adolescence (16 to 18 years).
Existing hypertension and gestational hypertension were
associated with higher average offspring SBP and DBP at
7 years of age compared with those offspring whose mothers
had normotensive pregnancies in all of the models (Tables 3
and 4), with the associations attenuated toward the null after
adjusting for maternal characteristics and offspring height
and BMI (existing hypertension mean difference [95% CI]:
1.67 mm Hg [0.48, 2.86] for SBP, 1.32 mm Hg [0.41, 2.23]
for DBP; gestational hypertension: 1.98 mm Hg [1.32, 2.65]
for SBP, 0.97 mm Hg [0.46, 1.48] for DBP [Model 3]). There
was no evidence to suggest a positive association between
preeclampsia and offspring BP at 7 years of age in the data
set with complete data on all covariables (preeclampsia:
1.22 mm Hg [0.52, 2.97] for SBP; 0.80 mm Hg [0.53,
2.13] for DBP [Model 3]).
There was no clear further attenuation of the associations
of existing hypertension and gestational hypertension with
offspring SBP and DBP at 7 years of age after the additional
adjustment for perinatal factors (birth weight, gestational age,
and mode of delivery). However, there was a decrease in the
mean differences in SBP and DBP at 7 years of age between
the preeclampsia and normotensive groups after adjusting for
these mediators (0.56 mm Hg [1.19, 2.31] for SBP,
0.49 mm Hg [0.85, 1.83] for DBP [Model 4]).
In all of the models, there was no evidence that the
average linear slopes for offspring BP within each of the
periods of childhood and adolescence (7 to 12 years, 12 to
16 years, and 16 to 18 years) differed by HDP status
(Tables 3 and 4).
Associations of Maternal BP Changes During
Pregnancy and Offspring BP
There was strong evidence that a higher maternal SBP at
8 weeks’ gestation was associated with higher average
offspring SBP at 7 years of age (Table 5), with the association
attenuating but remaining strong after adjusting for the
potential maternal and offspring confounders (1.13 mm Hg
[0.56, 1.71]; Model 2). However, there was no further
attenuation after the additional adjustment for birth weight,
gestational age, and mode of delivery. Similarly, there was
strong evidence that a higher maternal DBP at 8 weeks’
DOI: 10.1161/JAHA.114.001422 Journal of the American Heart Association 4
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Table 1. Characteristics in the Eligible Cohorts and in the Subset of Mother–Offspring Pairs With Complete Data on All
Covariables
BP Measurements
Full Data Set for HDP Analysis
(Total, N=8443) Median (LQ, UQ)
Full Data Set for Maternal BP Analysis
(Total, N=8617) Median (LQ, UQ)
Complete Data on all Covariables (N=6619)
Median (LQ, UQ)
Offspring BP measurements 5 (3, 7) 5 (3, 7) 6 (3, 7)
Maternal BP measurements 14 (11, 16) 14 (11, 16) 14 (12, 16)
Thinned maternal BP measurements* 10 (9, 12) 11 (9, 12) 10 (9, 12)
Continuous Characteristics Mean (SD) [N] Mean (SD) [N] Mean (SD)
Maternal age, years 28.7 (4.7) [8443] 28.7 (4.7) [8617] 29.0 (4.6)
Gestational age, weeks 39.5 (1.8) [8443] 39.5 (1.8) [8617] 39.6 (1.7)
Birth weight, g 3434 (534) [8360] 3432 (534) [8521] 3451 (511)
Maternal pre-pregnancy BMI, kg/m2 22.9 (3.8) [7483] 22.9 (3.8) [7634] 22.9 (3.8)
Categorical Characteristics n (%) [N] n (%) [N] n (%)
HDP
No HDP 6716 (79.5) [8443] 6716 (79.5) [8443] 5295 (80.0)
Existing hypertension 310 (3.7) [8443] 310 (3.7) [8443] 253 (3.8)
Gestational hypertension 1256 (14.9) [8443] 1256 (14.9) [8443] 954 (14.4)
Preeclampsia 161 (1.9) [8443] 161 (1.9) [8443] 117 (1.8)
Smoking during pregnancy
Never smoked 5851 (72.0) [8130] 5985 (72.1) [8299] 4893 (73.9)
Smoked prepregnancy/first trimester 979 (12.0) [8130] 995 (12.0) [8299] 763 (11.5)
Smoked throughout pregnancy 1300 (16.0) [8130] 1319 (15.9) [8299] 963 (14.6)
Parity
Multiparous 4317 (53.3) [8093] 4427 (53.6) [8261] 3530 (53.3)
Nulliparous 3776 (46.7) [8093] 3834 (46.4) [8261] 3089 (46.7)
Mother’s education
CSE/vocational 1967 (24.5) [8008] 2001 (24.5) [8172] 1437 (21.7)
O-level 2835 (35.4) [8008] 2889 (35.3) [8172] 2388 (36.1)
A-level 2015 (25.2) [8008] 2056 (25.2) [8172] 1745 (26.4)
Degree 1191 (14.9) [8008] 1226 (15.0) [8172] 1049 (15.8)
Cesarean section
Yes 874 (10.4) [8402] 879 (10.3) [8542] 670 (10.1)
No 7528 (89.6) [8402] 7663 (89.7) [8542] 5949 (89.9)
Head of household social class
I 1131 (14.9) [7599] 1164 (15.0) [7749] 1020 (15.4)
II 3325 (43.7) [7599] 3392 (43.8) [7749] 2934 (44.3)
III 1920 (25.3) [7599] 1947 (25.1) [7749] 1657 (25.0)
IV 864 (11.4) [7599] 876 (11.3) [7749] 713 (10.8)
V 359 (4.7) [7599] 370 (4.8) [7749] 295 (4.5)
Offspring gender
Male 4247 (50.3) [8443] 4334 (50.3) [8617] 3335 (50.4)
Female 4196 (49.7) [8443] 4283 (49.7) [8617] 3284 (49.6)
Head of household social class is determined using the highest parental occupation within the family, with class I referring to a professional/managerial role down to class V, which referred to
an unskilled manual role. A-level indicates an educational qualiﬁcation generally acquired at school age 18 years; BMI body mass index; BP, blood pressure; CSE, Certiﬁcate of Secondary
Education; HDP, hypertensive disorder of pregnancy; LQ, lower quartile; O-level, an educational qualiﬁcation acquired at school age 16 years; UQ, upper quartile.
*TopreventmotherswithmanyBPmeasurementshaving toomuch inﬂuenceon thesubsequent analyses,we thinned thedata by randomly sampling1measurement for every2-weekperiodof gestation.
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Table 2. Distributions of Maternal and Offspring Characteristics for the Full Data Set by HDP Status (N=8443)
BP Measurements
Median (LQ, UQ) by HDP Category
No HDP Existing Hypertension Gestational Hypertension Preeclampsia
Offspring BP measurements 5 (3, 7) 6 (3, 7) 5 (3, 7) 5 (3, 7)
Maternal BP measurements 13 (11, 15) 15 (12, 20) 16 (14, 20) 19 (15, 26)
Thinned maternal BP measurements* 10 (9, 11) 11 (10, 12) 11 (9, 12) 10 (9, 11)
Continuous Characteristics
Mean (SD) [N] by HDP Category
P Value **No HDP Existing Hypertension Gestational Hypertension Preeclampsia
Maternal age, years 28.7 (4.7) [6716] 28.8 (4.7) [310] 28.4 (4.9) [1256] 28.4 (5.4) [161] 0.344
Gestational age, weeks 39.5 (1.7) [6716] 39.2 (2.1) [310] 39.6 (1.8) [1256] 38.0 (3.0) [161] <0.001
Birth weight, g 3443 (511) [6650] 3377 (597) [308] 3449 (562) [1244] 3029 (858) [158] <0.001
Maternal pre-pregnancy BMI, kg/m2 22.5 (3.3) [5970] 24.6 (5.0) [285] 24.7 (4.8) [1087] 24.9 (5.3) [141] <0.001
Categorical Characteristics
n (%) [N] by HDP Category
P Value†No HDP Existing Hypertension Gestational Hypertension Preeclampsia
Smoking during pregnancy
Never smoked 4595 (71.0) [6475] 230 (76.7) [300] 910 (75.6) [1204] 116 (76.8) [151]
Smoked prepregnancy/first trimester 781 (12.0) [6475] 31 (10.3) [300] 142 (11.8) [1204] 25 (16.6) [151] <0.001
Smoked throughout pregnancy 1099 (17.0) [6475] 39 (13.0) [300] 152 (12.6) [1204] 10 (6.6) [151]
Parity
Multiparous 3648 (56.7) [6438] 141 (46.8) [301] 488 (40.5) [1204] 40 (26.7) [150] <0.001
Nulliparous 2790 (43.3) [6438] 160 (53.2) [301] 716 (59.5) [1204] 110 (73.3) [150]
Mother’s education
CSE/vocational 1598 (25.1) [6372] 62 (20.7) [299] 271 (22.9) [1185] 36 (23.7) [152]
O-level 2205 (34.6) [6372] 134 (44.8) [299] 440 (37.1) [1185] 56 (36.8) [152] 0.032
A-level 1621 (25.4) [6372] 63 (21.1) [299] 289 (24.4) [1185] 42 (27.6) [152]
Degree 948 (14.9) [6372] 40 (13.4) [299] 185 (15.6) [1185] 18 (11.8) [152]
Cesarean section
Yes 602 (9.0) [6682] 38 (12.3) [309] 185 (14.8) [1250] 49 (30.4) [161] <0.001
No 6080 (91.0) [6682] 271 (87.7) [309] 1065 (85.2) [1250] 112 (69.6) [161]
Head of household social class
I 916 (15.1) [6045] 32 (11.0) [292] 168 (15.0) [1123] 15 (10.8) [139]
II 2647 (43.8) [6045] 131 (44.9) [292] 481 (42.8) [1123] 66 (47.5) [139]
III 1507 (24.9) [6045] 79 (27.0) [292] 302 (26.9) [1123] 32 (29.0) [139] 0.696
IV 687 (11.4) [6045] 36 (12.3) [292] 122 (10.9) [1123] 19 (13.7) [139]
V 288 (4.8) [6045] 14 (4.8) [292] 50 (4.5) [1123] 7 (5.0) [139]
Offspring gender
Male 3350 (49.9) [6716] 164 (52.9) [310] 655 (52.1) [1256] 78 (48.5) [161] 0.354
Female 3366 (50.1) [6716] 146 (47.1) [310] 601 (47.9) [1256] 83 (51.5) [161]
Head of household social class is determined using the highest parental occupation within the family, with class I referring to a professional/managerial role down to class V which referred
to an unskilled manual role. A-level indicates an educational qualiﬁcation generally acquired at school age 18 years; BMI indicates body mass index; BP, blood pressure; CSE, Certiﬁcate of
Secondary Education; HDP, hypertensive disorder of pregnancy; LQ, lower quartile; O-level, an educational qualiﬁcation acquired at school age 16 years; UQ, upper quartile.
*To prevent mothers with many BP measurements having too much inﬂuence on the subsequent analyses, we thinned the data by randomly sampling 1 measurement for every 2-week
period of gestation.
**F-test for continuous characteristics on 3 DF testing the null hypothesis that the distributions of these continuous characteristics are the same across the 4 HDP categories.
†v2 test for categorical characteristics on (n1)(m1) DF testing for associations between the variable and HDP.
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gestation was associated with higher average offspring DBP at
7 years of age in the unadjusted model (Model 1; Table 6).
This association attenuated but remained after adjusting for
maternal and offspring characteristics (0.75 mm Hg [0.04,
1.47]; Model 2).
There was some weak evidence of positive associations
between maternal SBP changes in all periods of gestation
and offspring SBP at age 7 in Model 1, although the
associations of maternal SBP change in 8 to 18, 18 to 30,
and >36 weeks’ gestation attenuated toward the null in
Model 2 and the association relating to maternal SBP
change in 30 to 36 weeks’ gestation attenuated after
adjustment for intrauterine mediators (Model 3; Table 5).
The associations of maternal DBP changes during pregnancy
with offspring DBP at age 7 tended to be weaker than those
for SBP with little evidence to support them, although there
was some weak evidence of a positive association between
maternal DBP change up to 18 weeks’ gestation and
offspring DBP at age 7 in all models (Table 6). There was
no evidence that SBP or DBP in early pregnancy or changes
in SBP or DBP during pregnancy were associated with
changes in offspring BP during childhood in any models
(Tables 5 and 6).
We repeated the analysis just in those mother–offspring
pairs where the mothers had normotensive pregnancies
(results available from authors on request). The results were
similar to those of the full analysis, with the 1 exception that
there was strong evidence in confounder-adjusted models
that maternal SBP change from 8 to 18 weeks’ gestation was
positively associated with offspring SBP at 7 years of age
(1.51 mm Hg [0.41, 2.64]). This association was not
explained by gestational age, birth weight, and mode of
delivery.
The results of each of the sensitivity analyses (adjusting for
breastfeeding, excluding women/offspring with few or many
BP measures or excluding women who took antihypertensive
medications) were not meaningfully different from those in
the main analysis (results available from authors on request).
Discussion
In this large general population birth cohort, we found that
offspring of women who had any of existing hypertension,
gestational hypertension, or preeclampsia had on average
higher BP at 7 years of age compared with offspring whose
mothers had normotensive pregnancies, although the differ-
ence in offspring BP associated with preeclampsia was not
supported by strong statistical evidence and conﬁdence
intervals were consistent with the null. The difference in BP in
midchildhood remained of a similar size up to age 18 years
for all hypertensive disorders as the BP trajectories across
childhood and adolescence had similar shapes in offspring
from all groups of maternal HDP but were consistently higher
in those women with any form of hypertension, as seen in
Figure. The associations of existing and gestational hyperten-
sion with offspring BP across childhood and adolescence
remained in confounder-adjusted models including after
adjustment for offspring and maternal BMI. Furthermore,
they did not appear to be mediated by birth weight,
gestational age, or mode of delivery. Despite associations of
preeclampsia with offspring BP being consistent with the null
in confounder-adjusted models, the point estimate for the
association was similar to that for gestational hypertension
and was imprecisely estimated due to the relatively small
number of women with preeclampsia. We also found a strong
positive association of maternal BP at 8 weeks’ gestation with
offspring BP in childhood, but much weaker associations of
change in BP during pregnancy with offspring BP.
Previous studies in ALSPAC6,7,16 and other cohorts8–14
have shown greater BP at a single point in childhood in
offspring of mothers with gestational hypertension or pre-
A
B
Figure. Average offspring SBP and DBP trajectories by HDP
status (N=8443). A, SBP. B, DBP. DBP indicates diastolic blood
pressure; HDP, hypertensive disorder of pregnancy; SBP, systolic
blood pressure.
DOI: 10.1161/JAHA.114.001422 Journal of the American Heart Association 7















 at UNIV OF ADELAIDE on May 25, 2016http://jaha.ahajournals.org/Downloaded from 
eclampsia compared to offspring of mothers with normal
pregnancies. Our study extends these studies, ﬁrst by
comparing associations of existing hypertension at the start
of pregnancy with offspring BP to those seen for pregnancy-
induced hypertension, and second by examining associations
with BP change trajectories across childhood. The mean
differences in offspring BP between children exposed to
maternal gestational hypertension or preeclampsia that we
found in this study at mean age 7 years are consistent with
these previous studies, including with a recent meta-analy-
sis.16 This meta-analysis reported that the mean difference in
SBP between offspring of preeclamptic and normotensive
pregnancies at ages <10 years was 2.91 mm Hg (95% CI:
1.55 to 4.27) and at ages ≥10 years was 2.24 mm Hg (1.49
to 2.98), suggesting a similar absolute difference in SBP at
different stages of childhood. Yet it is important to note that
these 2 estimates were based on different studies, meaning
that a direct inference of how the difference in blood pressure
alters with age in the same children is not possible. We found
that the absolute difference in SBP and DBP between
offspring of hypertensive pregnancies and offspring of
normotensive pregnancies remained similar between the ages
of 7 to 18 years. Despite the increase in BP in all groups up to
the age of 16 years, the relative difference in BP (as a
percentage of total BP) also remained similar over this age
range, with no clear decreasing trend. Given that BP has been
shown to track from childhood into adulthood,35 and that
blood pressure in young adulthood has been demonstrated to
be related to mortality from cardiovascular disease, coronary
heart disease, and stroke in later life,36 the differences that
we have found, and their consistency across childhood and
adolescence, suggest that offspring of hypertensive pregnan-
cies may be subject to a higher cardiovascular risk across the
lifecourse than offspring of normotensive pregnancies.
The associations that we have observed may be driven by
shared genetic or environmental factors between the mother
and child. This is supported by a study showing that genetic
variants that are associated with adult BP in genomewide
Table 3. Mean Differences (95% CI) in SBP at 7 Years and Average Change in SBP in Each Period of Childhood and Adolescence
by HDP Status (N=6619)
Models
Mean Difference in SBP at
7 Years of Age (mm Hg)
Mean Difference in Average SBP Changes (mm Hg/Year)
7 to 12 Years 12 to 16 Years >16 Years
Model 1
No HDP 0 0 0 0
Existing hypertension 2.13 (0.87, 3.38) 0.10 (0.19, 0.40) 0.29 (0.22, 0.80) 0.16 (1.36, 1.04)
Gestational hypertension 2.51 (1.82, 3.20) 0.02 (0.14, 0.18) 0.04 (0.33, 0.25) 0.11 (0.58, 0.80)
Preeclampsia 1.45 (0.39, 3.29) 0.20 (0.24, 0.64) 0.33 (0.47, 1.13) 0.02 (1.84, 1.80)
Model 2
No HDP 0 0 0 0
Existing hypertension 1.79 (0.53, 3.05) 0.08 (0.22, 0.38) 0.19 (0.31, 0.68) 0.37 (1.53, 0.78)
Gestational hypertension 2.14 (1.44, 2.85) 0.01 (0.17, 0.17) 0.09 (0.38, 0.19) 0.15 (0.53, 0.83)
Preeclampsia 1.04 (0.81, 2.88) 0.15 (0.29, 0.59) 0.13 (0.64, 0.90) 0.11 (1.65, 1.88)
Model 3
No HDP 0 0 0 0
Existing hypertension 1.67 (0.48, 2.86) 0.12 (0.17, 0.41) 0.18 (0.31, 0.66) 0.28 (1.40, 0.84)
Gestational hypertension 1.98 (1.32, 2.65) 0.03 (0.19, 0.14) 0.08 (0.36, 0.20) 0.12 (0.55, 0.78)
Preeclampsia 1.22 (0.52, 2.97) 0.19 (0.24, 0.61) 0.13 (0.63, 0.89) 0.28 (2.00, 1.44)
Model 4
No HDP 0 0 0 0
Existing hypertension 1.47 (0.28, 2.66) 0.12 (0.17, 0.41) 0.16 (0.32, 0.65) 0.29 (1.41, 0.83)
Gestational hypertension 1.92 (1.26, 2.59) 0.03 (0.20, 0.13) 0.09 (0.37, 0.19) 0.15 (0.52, 0.81)
Preeclampsia 0.56 (1.19, 2.31) 0.20 (0.24, 0.63) 0.08 (0.68, 0.84) 0.34 (2.07, 1.39)
Model 1 is the unadjusted model. Model 2 is adjusted for the maternal characteristics: prepregnancy BMI, maternal age, parity, smoking during pregnancy, and education, as well as head
of household social class and offspring sex. Model 3 is additionally adjusted for offspring BMI and height. Model 4 is adjusted for birth weight, mode of delivery, and gestational age in
addition to those covariables adjusted for in Model 3. In the reference category (normotensive pregnancy), for Model 1, mean SBP at 7 years (SE) [mm Hg]=97.54 (0.14); mean SBP
change (SE) [mm Hg/year]: 7 to 12 years=1.73 (0.04), 12 to 16 years=4.91 (0.06), >16 years=4.34 (0.35). BMI indicates body mass index; HDP, hypertensive disorders of pregnancy;
SBP, systolic blood pressure.
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association studies were associated with childhood BP from
at least age 6 years, with the genetic effect on BP remaining
similar from ages 6 to 17 years.27 We have adjusted for many
potential confounders to attempt to account for shared
environmental factors, but it is possible that unmeasured
factors could have contributed to the associations we
observed. Alternatively, the associations may be explained
by a direct inﬂuence of maternal HDP on the development of
the fetal cardiovascular system in utero. Preeclampsia is often
characterized by poor formation of the placental blood supply
and could therefore affect intrauterine development via a
reduced supply of nutrients to the fetus.37 Alternatively, fetal
development may be affected by intrauterine exposure to the
systemic inﬂammation, which is associated with HDP.38 As
there are similar-sized associations of each form of HDP with
offspring BP, this may suggest that the mechanisms driving
each of these associations are similar. However, the point
estimate for the association of preeclampsia with offspring BP
at 7 years of age did attenuate with adjustment for media-
tion by birth weight, gestational age, and mode of delivery,
consistent with our earlier work looking at cross-sectional
associations only with offspring BP at 10 and 11 years of age
in the ALSPAC study,6,7 while the associations of gestational
hypertension and existing hypertension with offspring BP
remained similar. This suggests that the association of
maternal preeclampsia with offspring BP may act via a
different pathway from that seen for gestational hypertension
and existing hypertension and that at least part of it may be
explained by poor development of the fetus in utero.
Our analysis relating trajectories of maternal BP during
pregnancy to offspring BP showed only weak evidence that
pregnancy-related changes in BP were associated with
offspring BP, but clearly demonstrated that a higher BP in
early pregnancy was associated with higher offspring BP in
childhood. These ﬁndings contrast with our previous study in
this cohort where we have shown strong associations of
greater increases in BP in the second half of pregnancy with
reduced fetal growth and no association of early-pregnancy
Table 4. Mean Differences (95% CI) in DBP at 7 Years and Average Change in DBP in Each Period of Childhood and Adolescence
by HDP Status (N=6619)
Models
Mean Difference in DBP at
7 Years of Age (mm Hg)
Mean Difference in Average DBP Changes (mm Hg/Year)
7 to 12 Years 12 to 16 Years >16 Years
Model 1
No HDP 0 0 0 0
Existing hypertension 1.36 (0.44, 2.28) 0.01 (0.22, 0.24) 0.19 (0.24, 0.62) 0.33 (1.31, 0.65)
Gestational hypertension 1.07 (0.57, 1.57) 0.01 (0.13, 0.12) 0.12 (0.12, 0.37) 0.29 (0.86, 0.28)
Preeclampsia 0.84 (0.50, 2.18) 0.06 (0.28, 0.40) 0.15 (0.82, 0.52) 1.11 (0.40, 2.61)
Model 2
No HDP 0 0 0 0
Existing hypertension 1.30 (0.38, 2.22) 0.03 (0.26, 0.20) 0.22 (0.21, 0.65) 0.35 (1.33, 0.63)
Gestational hypertension 1.00 (0.48, 1.51) 0.05 (0.18, 0.08) 0.18 (0.07, 0.43) 0.39 (0.98, 0.19)
Preeclampsia 0.78 (0.56, 2.13) 0.03 (0.37, 0.31) 0.04 (0.72, 0.63) 0.88 (0.62, 2.39)
Model 3
No HDP 0 0 0 0
Existing hypertension 1.32 (0.41, 2.23) 0.01 (0.24, 0.22) 0.22 (0.21, 0.65) 0.33 (1.31, 0.65)
Gestational hypertension 0.97 (0.46, 1.48) 0.06 (0.19, 0.07) 0.19 (0.07, 0.44) 0.41 (0.99, 0.17)
Preeclampsia 0.80 (0.53, 2.13) 0.01 (0.35, 0.33) 0.04 (0.71, 0.63) 0.73 (0.77, 2.23)
Model 4
No HDP 0 0 0 0
Existing hypertension 1.22 (0.31, 2.13) 0.01 (0.22, 0.24) 0.21 (0.22, 0.65) 0.34 (1.32, 0.64)
Gestational hypertension 0.96 (0.45, 1.47) 0.06 (0.19, 0.07) 0.20 (0.06, 0.45) 0.43 (1.01, 0.15)
Preeclampsia 0.49 (0.85, 1.83) 0.05 (0.29, 0.39) 0.05 (0.72, 0.63) 0.67 (0.85, 2.18)
Model 1 is the unadjusted model. Model 2 is adjusted for the maternal characteristics: prepregnancy BMI, maternal age, parity, smoking during pregnancy, and education, as well as head
of household social class and offspring sex. Model 3 is additionally adjusted for offspring BMI and height. Model 4 is adjusted for birth weight, mode of delivery, and gestational age in
addition to those covariables adjusted for in Model 3. In the reference category (normotensive pregnancy), for Model 1, mean DBP at 7 years (SE) [mm Hg]=56.52 (0.10); mean DBP
change (SE) [mm Hg/year]: 7 to 12 years=0.10 (0.03), 12 to 16 years=2.66 (0.05), >16 years=2.20 (0.11). BMI indicates body mass index; DBP, diastolic blood pressure; HDP,
hypertensive disorders of pregnancy.
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DBP with this outcome, although early-pregnancy SBP was
negatively associated with size at birth. Similarly, a greater
rise in BP was associated with a shorter gestation, while the
early-pregnancy level of BP was not.39 While we cannot rule
out the possibility that there were small associations of
maternal BP change with offspring BP that we did not have the
power to detect here, the strong positive associations of
early-pregnancy BP with offspring BP that we found suggest a
non-pregnancy-related driver of the relationship between HDP
and offspring BP. This may act, for example, via a maternal
predisposition to high BP rather than an adverse response to
the presence of the fetus.40 However, we had few measure-
ments of BP prior to 8 weeks of gestation, and it is possible
that BP may have changed from prepregnancy values by this
point. Early gestation is also a key period for epigenetic
reprogramming, and thus a speciﬁc association of BP in early
pregnancy with offspring BP may be indicative of epigenetic
mechanisms that occur at this particular stage of fetal
development.41 Differences in DNA methylation patterns have
been found between placentas of pregnancies affected by
preeclampsia and placentas of normal pregnancies, which
suggest that epigenetics plays a part in trophoblast invasion
and placental development.42
The main strengths of this study are its size and the
repeated measurements of BP taken in the mothers during
pregnancy and in the offspring during childhood and adoles-
cence. The large number of variables recorded has also
allowed for in-depth consideration of potential confounders
and the investigation of possible mediating variables.
As with all general population cohort studies, there is loss to
follow-up and there are missing data. However, the sensitivity
analyses excluding mothers and offspring who had few
measurements of BP available gave similar results to those
of the main analyses where all mother–offspring pairs who had
complete data on all covariables were included. This suggests
that our results have not been markedly biased by missing BP
measurements. We excluded mother–offspring pairs who did
not have complete data on all covariables, and these mothers
were slightly less likely to smoke during pregnancy and likely to
be of a higher education level than those excluded. However,
we have no reason to expect that the associations that we have
observed would differ by the mother’s smoking or education
status. Another limitation of this study is that the measure-
ments of BP both in the mothers and the offspring were taken
using different measuring devices and by different observers.
Hence, these measurements of BP are likely to be subject to
Table 5. Mean Differences (95% CI) in Offspring SBP at 7 Years and Average Changes in Offspring SBP in Each Age Interval Given
a 10-mm Hg Increase in Maternal SBP at 8 Weeks of Gestation or per 1 mm Hg/Week Increase in Maternal SBP Change in Each
Period of Gestation (N=6619)
Model Maternal SBP Variable
Mean Difference in
Offspring SBP at
7 Years (mm Hg)
Mean Difference in Average Offspring SBP Change (mm Hg/Year)
7 to 12 Years 12 to 16 Years >16 Years
Model 1 SBP at 8 weeks (per 10 mm Hg) 1.53 (1.03, 2.03) 0.03 (0.14, 0.09) 0.09 (0.12, 0.30) 0.03 (0.46, 0.53)
SBP change 8 to 18 weeks (mm Hg/week) 1.43 (0.17, 2.71) 0.08 (0.22, 0.40) 0.06 (0.61, 0.47) 0.30 (0.96, 1.60)
SBP change 18 to 30 weeks (mm Hg/week) 1.36 (0.10, 2.68) 0.04 (0.36, 0.26) 0.13 (0.40, 0.67) 0.32 (1.59, 0.96)
SBP change 30 to 36 weeks (mm Hg/week) 0.38 (0.10, 0.88) 0.11 (0.01, 0.23) 0.16 (0.38, 0.05) 0.28 (0.22, 0.79)
SBP change >36 weeks (mm Hg/week) 0.56 (0.14, 1.00) 0.06 (0.16, 0.04) 0.04 (0.14, 0.23) 0.25 (0.70, 0.17)
Model 2 SBP at 8 weeks (per 10 mm Hg) 1.13 (0.56, 1.71) 0.07 (0.21, 0.07) 0.10 (0.13, 0.35) 0.02 (0.58, 0.55)
SBP change 8 to 18 weeks (mm Hg/week) 1.06 (0.17, 2.32) 0.03 (0.27, 0.34) 0.02 (0.56, 0.53) 0.51 (0.75, 1.78)
SBP change 18 to 30 weeks (mm Hg/week) 0.88 (0.43, 2.16) 0.05 (0.37, 0.27) 0.01 (0.55, 0.56) 0.07 (1.40, 1.22)
SBP change 30 to 36 weeks (mm Hg/week) 0.52 (0.02, 1.07) 0.09 (0.04, 0.22) 0.16 (0.39, 0.07) 0.26 (0.27, 0.78)
SBP change >36 weeks (mm Hg/week) 0.50 (0.04, 0.99) 0.04 (0.16, 0.08) 0.05 (0.15, 0.25) 0.16 (0.65, 0.31)
Model 3 SBP at 8 weeks (per 10 mm Hg) 1.13 (0.55, 1.70) 0.07 (0.21, 0.07) 0.10 (0.14, 0.35) 0.01 (0.56, 0.57)
SBP change 8 to 18 weeks (mm Hg/week) 1.16 (0.06, 2.42) 0.04 (0.26, 0.35) 0.01 (0.52, 0.56) 0.39 (0.87, 1.65)
SBP change 18 to 30 weeks (mm Hg/week) 0.78 (0.53, 2.04) 0.05 (0.37, 0.27) 0.01 (0.55, 0.56) 0.09 (1.41, 1.19)
SBP change 30 to 36 weeks (mm Hg/week) 0.30 (0.24, 0.85) 0.09 (0.04, 0.23) 0.18 (0.42, 0.04) 0.24 (0.28, 0.76)
SBP change >36 weeks (mm Hg/week) 0.50 (0.05, 0.99) 0.03 (0.15, 0.08) 0.06 (0.14, 0.26) 0.19 (0.68, 0.28)
Model 1 was adjusted only for maternal SBP at 8 weeks’ gestation and change in maternal SBP in any earlier periods of gestation. Model 2 is adjusted for the maternal characteristics:
HDP status (only in the maternal SBP part of the model, as it is wholly pregnancy related), prepregnancy BMI, maternal age, parity, smoking during pregnancy, and education (maternal
education was only included in the maternal SBP part of the model, to assist with model convergence), as well as head of household social class and offspring sex, BMI, and height (only in
the offspring SBP part of the model). Model 3 is additionally adjusted for birth weight, gestational age, and mode of delivery in the offspring SBP part of the model. BMI indicates body mass
index; HDP, hypertensive disorders of pregnancy; SBP, systolic blood pressure.
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some degree of variability between observers and devices.
Maternal measurements were also subject to end-digit pref-
erence for zero. However, we would expect only random
nondifferential measurement error, which could potentially
dilute our ﬁndings. Existing hypertension was obtained through
self-report of ever being diagnosed as having high BP, and this
may be biased. Nevertheless, the fact that this is associated
with higher offspring BP provides some face-validity for its
accuracy. The study was also limited by the relatively small
number of women who had preeclampsia. This meant that
there was low power to detect a difference in offspring BP in
this group compared with normotensive pregnancies and that
we obtained imprecise estimates of the associations of
maternal preeclampsia with offspring BP trajectories.
Perspectives
Our ﬁndings suggest that maternal hypertension during preg-
nancy is associated with increased offspring BP during
childhood and adolescence. These associations do not
strengthen or weaken with age over the age range that we
have examined (7 to 18 years), showing that offspring of
women who experience hypertension in pregnancy have
consistently higher BP from at least age 7 into early adulthood.
Maternal BP at 8 weeks’ gestation was also positively associ-
ated with offspring BP in childhood, but changes in BP during
pregnancy were not strongly associated with offspring BP. This
suggests that the associations are inﬂuenced by a maternal
susceptibility to high BP that precedes pregnancy.
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Model Maternal DBP Variable
Mean Difference in
Offspring DBP at
7 Years (mm Hg)
Mean Difference in Average Offspring DBP Change (mm Hg/Year)
7 to 12 Years 12 to 16 Years >16 Years
Model 1 DBP at 8 weeks (per 10 mm Hg) 0.83 (0.28, 1.39) 0.05 (0.09, 0.20) 0.06 (0.21, 0.34) 0.27 (0.36, 0.91)
DBP change 8 to 18 weeks (mm Hg/week) 1.47 (0.20, 3.27) 0.02 (0.41, 0.45) 0.32 (1.20, 0.55) 0.73 (2.82, 1.19)
DBP change 18 to 30 weeks (mm Hg/week) 1.08 (0.25, 2.37) 0.06 (0.39, 0.27) 0.11 (0.54, 0.78) 0.46 (1.01, 2.00)
DBP change 30 to 36 weeks (mm Hg/week) 0.11 (0.30, 0.53) 0.01 (0.09, 0.11) 0.05 (0.15, 0.25) 0.19 (0.65, 0.26)
DBP change >36 weeks (mm Hg/week) 0.24 (0.02, 0.51) 0.05 (0.11, 0.02) 0.12 (0.01, 0.25) 0.04 (0.34, 0.26)
Model 2 DBP at 8 weeks (per 10 mm Hg) 0.75 (0.04, 1.47) 0.05 (0.13, 0.24) 0.03 (0.33, 0.39) 0.62 (0.20, 1.44)
DBP change 8 to 18 weeks (mm Hg/week) 1.52 (0.21, 3.38) 0.05 (0.50, 0.40) 0.19 (1.10, 0.71) 1.29 (3.60, 0.70)
DBP change 18 to 30 weeks (mm Hg/week) 0.92 (0.49, 2.30) 0.06 (0.42, 0.29) 0.02 (0.67, 0.73) 0.69 (0.88, 2.41)
DBP change 30 to 36 weeks (mm Hg/week) 0.16 (0.28, 0.60) 0.01 (0.11, 0.11) 0.04 (0.18, 0.25) 0.15 (0.66, 0.33)
DBP change >36 weeks (mm Hg/week) 0.24 (0.07, 0.56) 0.06 (0.14, 0.02) 0.15 (0.01, 0.30) 0.09 (0.47, 0.29)
Model 3 DBP at 8 weeks (per 10 mm Hg) 0.78 (0.06, 1.50) 0.04 (0.14, 0.23) 0.03 (0.32, 0.39) 0.62 (0.20, 1.44)
DBP change 8 to 18 weeks (mm Hg/week) 1.51 (0.21, 3.38) 0.03 (0.48, 0.42) 0.22 (1.13, 0.68) 1.26 (3.58, 0.73)
DBP change 18 to 30 weeks (mm Hg/week) 0.74 (0.68, 2.11) 0.03 (0.39, 0.32) 0.03 (0.66, 0.74) 0.65 (0.93, 2.37)
DBP change 30 to 36 weeks (mm Hg/week) 0.02 (0.42, 0.46) 0.03 (0.08, 0.14) 0.05 (0.17, 0.26) 0.19 (0.69, 0.29)
DBP change >36 weeks (mm Hg/week) 0.23 (0.09, 0.55) 0.05 (0.13, 0.03) 0.14 (0.02, 0.29) 0.08 (0.46, 0.29)
Model 1 was adjusted only for maternal DBP at 8 weeks’ gestation and change in maternal DBP in any earlier periods of gestation. Model 2 is adjusted for the maternal characteristics:
HDP status (only in the maternal DBP part of the model, as it is wholly pregnancy related), prepregnancy BMI, maternal age, parity, smoking during pregnancy, and education (maternal
education was only included in the maternal DBP part of the model, to assist with model convergence), as well as head of household social class and offspring sex, BMI, and height (only in
the offspring DBP part of the model). Model 3 is additionally adjusted for birth weight, gestational age, and mode of delivery in the offspring DBP part of the model. BMI indicates body
mass index; DBP, diastolic blood pressure.
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